Normal view MARC view ISBD view

Comorbidity of migraine and restless legs syndrome--a case-control study. [electronic resource]

By:

Rhode, A M

Contributor(s):

Producer: 20080110Description: 1255-60 p. digitalISSN:

0333-1024

Subject(s):

Online resources:

Available from publisher's website

In: Cephalalgia : an international journal of headache vol. 27

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

481 Stratification of randomization is not required for a pre-specified subgroup analysis.
by Kaiser, Lee D
482 Active controlled studies in antibiotic drug development.
by Dane, Aaron
483 Guidelines for accurate EC50/IC50 estimation.
by Sebaugh, J L
484 Asymptotic properties of mean survival estimate based on the Kaplan-Meier curve with an extrapolated tail.
by Gong, Qi
485 Stability criteria for the outcomes of statistical tests to assess drug effectiveness with a single study.
by De Martini, Daniele
486 An examination of the relative impact of type I and type II error rates in phase II drug screening trial queues.
by Hutson, Alan D
487 A practical comparison of blinded methods for sample size reviews in survival data clinical trials.
by Todd, Susan
488 Blinded assessment of treatment effects for survival endpoint in an ongoing trial.
by Xie, Jun
489 Comment on 'Inference on treatment effects for targeted clinical trials under enrichment design', Jen-Pei Liu, Jr-Rung Lin, and Shein-Chung Chow; Pharmaceutical Statistics 2009; 8:356-370.
by Chen, Lin
490 Determining the non-inferiority margin for patient reported outcomes.
by Gerlinger, Christoph
491 Designing a non-inferiority study in kidney transplantation: a case study.
by Witte, Steffen
492 10 Years with ICH E10: Choice of Control Groups.
by Rockhold, Frank W
493 Time to end the non-inferiority complex?
by Julious, Steven A
494 Modelling and simulation in the pharmaceutical industry--some reflections.
by Burman, Carl-Fredrik
495 Use the Correlation Coefficient to Summarize Regression Performance?
by Gorroochurn, Prakash
496 Mixed models for data from thorough QT studies: part 1. assessment of marginal QT prolongation.
by Schall, Robert
497 A new mathematical approach for the estimation of the AUC and its variability under different experimental designs in preclinical studies.
by Navarro-Fontestad, Carmen
498 The potential for bias in reporting of industry-sponsored clinical trials.
by Pyke, Stephen
499 Commentary.
by Snapinn, Steven
500 Additional results for 'Sequential design approaches for bioequivalence studies with crossover designs'.
by Montague, Timothy H